Home > About Chugai > Company Profile > Directors & Officers

Directors & Officers

Representative Directors

Osamu Nagayama
Chairman & CEO
Career Summary
  • 1978 Entered the Company
  • 1985 Deputy General Manager of Development and Planning Div. and Director
  • 1987 Director & Senior Vice President
  • 1989 Representative Director & Deputy President
  • 1992 Representative Director, President & CEO
  • 2010 Outside Director, Sony Corporation (to present)
  • 2012 Representative Director, Chairman & CEO (to present)
Motoo Ueno
Deputy Chairman, Corporate Social Responsibility, Audit
Career Summary
  • 1984 Entered the Company
  • 1991 General Manager of London Representative Office
  • 1993 Director
  • 1994 Director and General Manager of Medical Information Div.
  • 1995 Director and General Manager of Clinical Research & Development Division
  • 1996 Director and Deputy General Manager of Research and Development Division
  • 1997 Director & Senior Vice President
  • 1998 Senior Vice President
  • 2000 Director & Senior Vice President
  • 2002 Director & Deputy President
  • 2003 Director & Deputy President, Vice President
  • 2004 Representative Director & Deputy President
  • 2006 Representative Director & President, Chugai Pharma Manufacturing Co., Ltd.
  • 2012 Representative Director & Deputy Chairman (to present)
Tatsuro Kosaka
President & COO
Career Summary
  • 1976 Entered the Company
  • 1995 Deputy President of Chugai Pharma Europe Ltd. (U.K.)
  • 2000 General Manager of Business Strategy Planning Office
  • 2002 Vice President & General Manager of Corporate Planning Dept.
  • 2004 Senior Vice President & General Manager of Corporate Planning Dept.
  • 2005 Senior Vice President & Deputy Managing Director of Sales & Marketing Group, Senior Vice President & Head of Strategic Marketing Unit
  • 2008 Senior Vice President & Head of Lifecycle Management & Marketing Unit
  • 2010 Director & Executive Vice President, Head of Lifecycle Management & Marketing Unit
  • 2011 Director & Executive Vice President
  • 2012 Representative Director, President & COO (to present)

Directors

Yoshio Itaya
Executive Vice President CFO, General Manager of Finance Supervisory Div.
Career Summary
  • 2003 Entered the Company, Senior Specialist of Finance & Accounting Div.
  • 2006 Vice President and General Manager of Finance & Accounting Div.
  • 2007 Vice President and General Manager of Corporate Planning Dept.
  • 2010 Senior Vice President and General Manager of Finance Supervisory Div. and Finance & Accounting Dept.
  • 2011 Senior Vice President, CFO, General Manager of Finance Supervisory Div. (to present) and Finance & Accounting Dept.
  • 2012 Director, Executive Vice President & CFO (to present)
Yutaka Tanaka
Executive Vice President
Career Summary
  • 1984 Entered Nippon Roche K.K. (NR)
  • 2001 Department Manager of Product Research Dept. of Nippon Roche Research Center
  • 2002 Senior Specialist of Product Research Dept. of the Company
  • 2005 General Manager of Renal Disease Area Dept.
  • 2007 Vice President, General Manager of Clinical Research & Development Div.
  • 2009 Senior Vice President, General Manager of Clinical Research & Development Div. Senior Vice President, Head of Portfolio Management Unit
  • 2011 Senior Vice President, Head of Lifecycle Management & Marketing Unit
  • 2012 Senior Vice President, Head of Project & Lifecycle Management Unit
  • 2014 Director, Executive Vice President (to present)
Daniel O’Day
Chief Executive Officer of Roche Pharmaceuticals, Member of the Roche Corporate Executive Committee, Member of the Genentech Board of Directors
Career Summary
  • 1987 Entered Roche Pharma USA
  • 1995 Director Human Resources, Roche Pharma U.S.A.
  • 1996 Director Product Marketing, Roche Pharma U.S.A.
  • 1998 Business Unit Head, Arthritis and Respiratory, Roche Pharma Headquarters
  • 1999 Lifecycle Leader Tamiflu, Roche Pharma Headquarters
  • 2001 Head Corporate Planning, Roche Pharma Japan
  • 2003 General Manager, Roche Pharma Denmark
  • 2006 President & CEO of Roche Molecular Diagnostics
  • 2010 COO Roche Diagnostics Division, Member of the Corporate Executive Committee
  • 2012 COO Roche Pharmaceuticals Division, Member of the Roche Corporate Executive Committee, Member of the Genentech Board of Directors
  • 2013 Director of the Company (to present)
  • 2016 CEO Roche Pharmaceuticals, Member of the Roche Corporate Executive Committee, Member of the Genentech Board of Directors (to present)
Sophie Kornowski-Bonnet
Head of Roche Partnering and Member of the Roche Enlarged Corporate Executive Committee
Career Summary
  • 1985 Abbott Diagnostic Division – Paris – France, Scientific Manager
  • 1989 Abbott Pharmaceutical Products – Chicago, U.S.A., Marketing Research Analyst
  • 1990 Abbott Pharmaceutical Products – New York, U.S.A., Neuroscience Sales Representative
  • 1991 Sanofi Winthrop – New York, U.S.A., Director, Strategic Marketing, Diagnostic Imaging
  • 1994 Sanofi Winthrop – Paris, France, Director, Neuroscience Business Unit
  • 1996 Merck Sharp & Dohme Paris, France, Director, Marketing Research and Strategic Planning
  • 1997 Merck Sharp & Dohme Israel, Managing Director
  • 2000 Vice-President Arthritis and Analgesia Franchise, Merck & Co. Inc. U.S.A.
  • 2002 Merck Sharp & Dohme Paris, France, Director, Rheumatology Division
  • 2006 Merck Sharp & Dohme Paris, France, Director, Cardiovascular Division
  • 2007 Roche Pharma, France, General Manager
  • 2012 Head of Roche Partnering, Member of the Roche Enlarged Corporate Executive Committee (to present) Director of the Company (to present)

< Outside Directors >

Yasuo Ikeda*
Vice-Chairman of the Board of Directors, Musashi Academy of the Nezu Foundation, University Professor of Waseda University, Professor Emeritus of Keio University
Career Summary
  • 1979 Director of Keio University Hospital Blood Center
  • 1991 Professor of Internal Medicine of Keio University School of Medicine
  • 2001 Director of Keio University Center for Integrated Medical Research
  • 2005 Dean of Keio University School of Medicine
  • 2009 Professor Emeritus of Keio University (to present) Professor of Department of Life Science and Medical Bioscience of Graduate School of Advanced Science and Engineering of Faculty of Science and Engineering of Waseda University
  • 2010 Outside Director of the Company (to present)
  • 2013 Vice-Chairman of the Board of Directors, Musashi Academy of the Nezu Foundation (to present)
  • 2014 Specially Appointed Professor of Waseda University (to present)
Masayuki Oku*
Chairman of Sumitomo Mitsui Financial Group, Inc.
Career Summary
  • 1968 Entered The Sumitomo Bank, Ltd. (SB)
  • 1994 Director, SB
  • 1998 Managing Director, SB
  • 1999 Managing Director and Managing Executive Officer, SB
  • 2001 Senior Managing Director and Senior Managing Executive Officer, SB, Senior Managing Director and Senior Managing Executive Officer of Sumitomo Mitsui Banking Corporation (SMBC)
  • 2002 Senior Managing Director of Sumitomo Mitsui Financial Group, Inc. (SMFG)
  • 2003 Deputy President, SMBC
  • 2005 Chairman, SMFG (to present), President and Chief Executive Officer, SMBC
  • 2015 Outside Director of the Company (to present)
Franz B. Humer
Non-executive Chairman of Diageo Plc. (U.K.)
Career Summary
  • 1971 Entered ICME Zurich
  • 1973 Entered Schering Plough Corporation
  • 1981 Entered Glaxo Holdings plc
  • 1995 Member of the Board of Directors, Head of the Pharmaceuticals Division of F. Hoffmann-La Roche Ltd (FHLR)
  • 1996 COO of FHLR
  • 1998 CEO of ROCHE HOLDING LTD (RH)
  • 2001 Chairman of the Board of Directors and CEO of RH
  • 2002 Outside Director of the Company
  • 2008 Chairman of the Board of Directors of RH, Non-executive Chairman of Diageo Plc (U.K.) (to present)
  • 2009 Retired as Director of the Company
  • 2014 Outside Director of the Company (to present)
  • 2015 Director of Bial-Portela & Ca., S.A. (Portugal) (to present)
Yasuo Ikeda and Masayuki Oku are independent directors pursuant to the regulations of Tokyo Stock Exchange, Inc.

Audit & Supervisory Board Members

Kunitoshi Watanabe
Audit & Supervisory Board Member (full-time)
Career Summary
  • 2005 Entered the Company
  • 2007 General Manager of Risk Management & Compliance Dept.
  • 2009 General Manager of General Affairs Dept.
  • 2010 Vice President & General Manager of General Affairs Supervisory Div. and General Manager of General Affairs Dept.
  • 2011 Vice President & General Manager of General Affairs Dept.
  • 2013 Audit & Supervisory Board Member (full-time) (to present)
Shunji Yokoyama
Audit & Supervisory Board Member (full-time)
Career Summary
  • 1981 Entered the Company
  • 2002 General Manager of Clinical Research Dept. 1
  • 2004 Vice President, General Manager of Clinical Research & Development Div.
  • 2007 Vice President, Deputy General Manager of Corporate Regulatory Compliance & Quality Assurance Div. and Head of Drug Safety Unit
  • 2009 Vice President, General Manager of Drug Safety Div.
  • 2011 Vice President, Head of Quality & Regulatory Compliance Unit and General Manager of Drug Safety Div.
  • 2013 Senior Vice President, Head of Regulatory & Quality Management Unit (to present)
  • 2015 Audit & Supervisory Board Member (full-time) (to present)

< Audit & Supervisory Board Members (Outside)>

Hisashi Hara
General Representative of the Asia-Pacific region, The Law Office of Nagashima Ohno & Tsunematsu
Career Summary
  • 1975 Registered as an attorney-at-law (Dai-ichi Tokyo Bar Association)
  • 1975 Entered Nagashima & Ohno (currently, Nagashima, Ohno & Tsunematsu)
  • 1983 Partner of Nagashima & Ohno
  • 1991 Managing Partner of Nagashima & Ohno
  • 2006 Chairman of Nagashima, Ohno & Tsunematsu
  • 2006 Administrative Council Member of the University of Tokyo
  • 2008 Outside Corporate Auditor, JPMorgan Securities Japan Co., Ltd.
  • 2012 Outside Audit & Supervisory Board Member of the Company (to present)
  • 2013 General Representative of the Asia-Pacific region, The Law Office of Nagashima Ohno & Tsunematsu (to present)
Takaaki Nimura*
Representative of Nimura Certified Public Accountant Office, Outside Director and Chairman of Audit Committee of Sony Corporation
Career Summary
  • 1974 Entered Arthur Young & Co., Tokyo Office
  • 1980 Seconded to Asahi & Co., Osaka Office
  • 1983 Seconded to Arthur Young & Co., Los Angeles Office
  • 1989 Partner of Asahi Shinwa & Co.
  • 1993 Entered Showa Ota & Co.
  • 1997 Senior partner of Showa Ota & Co.
  • 2008 Executive Board Member of Ernst & Young ShinNihon LLC
  • 2010 Established Nimura Certified Public Accountant Office
  • 2012 Director of Sony Corporation (to present)
  • 2016 Outside Audit & Supervisory Board Member of the Company (to present)
Takaaki Nimura is an independent Audit & Supervisory Board Member pursuant to the regulations of Tokyo Stock Exchange, Inc.

Executive Officers

Yoshio Itaya
Executive Vice President, CFO, General Manager of Finance Supervisory Div.
Yutaka Tanaka
Executive Vice President
Yasushi Ito
Senior Vice President, Head of Project & Lifecycle Management Unit
Hisafumi Okabe
Senior Vice President, General Manager of Research Div.
Susumu Kato
Senior Vice President, General Manager of Marketing & Sales Div.
Hitoshi Kuboniwa
Senior Vice President
Shinya Unno
Senior Vice President, General Affairs and Secretarial
Mitsuru Kikuchi
Senior Vice President, External Affairs
Tetsuya Yamaguchi
Vice President, Department Manager of Business Development Dept.
Yoshiaki Ohhashi
Vice President, Head of Quality & Regulatory Compliance Unit and General Manager of Drug Safety Div.
Toshihiko Komori
Vice President, General Manager of Translational Clinical Research Div.
Hisanori Takanashi
Vice President, General Manager of Clinical Development Div.
Shinji Hidaka
Vice President, Deputy General Manager of Marketing & Sales Div. and Head of Primary Unit
Kouichi Nishikawa
Vice President, Deputy General Manager of Marketing & Sales Div. and Department Manager of Marketing Planning Dept.
Tadahiko Sato
Vice President, Supervisory Branch Manager of Tokyo Branch 1
Osamu Okuda
Vice President, General Manager of Corporate Planning Dept.
Toshiaki Itagaki
Vice President, General Manager of Finance & Accounting Dept.
Keiji Kono
Vice President, Global Health Policy, General Manager of IT Supervisory Div.
Mamoru Togashi
Vice President, General Manager of Human Resources Supervisory Div.
Junichi Ebihara
Vice President, General Manager of Legal Dept.
  • Print
  • View in Japanese